ArticleDiabetologia2017

The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype.

Ángela Vinué et al.PubMed ↗Publisher ↗

No numbers read from the abstract.